Abstract Background Total psoas muscle cross sectional area, as identified with computed tomography (CT), has been associated with clinical outcomes in various disease states. Unfortunately, total psoas CSA does not differentiate muscle density nor fat, both of which may be abnormal in obesity. Using a novel CT method to partition psoas muscle into low and high density muscle, recent studies have demonstrated low and high attenuating psoas muscle may be superior to total psoas CSA in identifying sarcopenic obesity. The impact of varying muscle composition in patients with inflammatory bowel disease is unknown. Methods We conducted a retrospective cohort study of IBD patients from a tertiary care center. Psoas muscle composition was determined using a novel and validated CT method. High and low attenuating bilateral psoas muscle was measured at the level of the 3rd lumbar vertebra. Clinical remission, surgery, hospitalization, and corticosteroid use were stratified by low and high density muscle and evaluated 6 weeks from the index CT. Results We identified 115 consecutive patients with a routine CT scan. Majority of patients had a greater quantity of low-density muscle (LDM), 95% had CD and 71% were not in clinical remission at the time of baseline CT. Of those with a greater quantity of LDM, 68% had history of IBD surgery and 60% were current/former smokers. The mean pre-CT body mass index (BMI) for the greater quantity LDM was significantly higher (p=0.002) than the mean pre-CTE BMI for those with low LDMC. Seventy percent with greater quantity of low-density muscle were either overweight or obese and 20% had a normal range BMI. Six months after the baseline CT, 53% in the lower quantity LDM had clinical remission, whereas 33.3% had remission in the high LDMC (p=0.05). Patients with greater quantity LDM were more likely to require corticosteroids in the 6 months after index CT, as compared to those with lower quantity LDM (p=0.02). Conclusion This observational study showed an association between greater quantity of LDM and obesity and worse IBD-related outcomes. This is the first study to evaluate the impact of muscle composition on IBD outcomes and our results offer a novel tool to risk stratify patients with IBD. Our study is limited by the retrospective nature, limited sample size, and narrow longitudinal follow-up. Larger prospective studies with greater longitudinal follow-up are needed to confirm our retrospective findings.
Read full abstract